Silo Pharma raises $2.1M in registered direct offering of 763,638 shares at $2.75

Silo Pharma, Inc.

Gross proceeds ~$2.1M from sale of 763,638 common shares at $2.75 each.
Concurrent private placement of warrants to buy 763,638 shares at $2.75, exercisable for 5 years.
H.C. Wainwright acted as exclusive placement agent; fees include 7.5% cash and 57,273 placement agent warrants.
Net proceeds to be used for working capital and general corporate purposes.
Offering closed on July 22, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.